Tag: transplant

May 9, 2018

Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs

Reata Pharmaceuticals (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company’s product development programs and announced financial...
May 9, 2018

Cardiol Therapeutics Appoints Dr. James Young as Chair of the Company’s Scientific Advisory Board

Cardiol Therapeutics Inc. (“Cardiol” or the “Company”), a nanotherapeutics company focused on the research and commercial development of proprietary drug...
May 2, 2018

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...
April 30, 2018

Key Stock Catalysts in the FDA Drug Application Process

Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

Kalytera Issues CEO Letter to Shareholders

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today issued the following letter to shareholders from the Company’s President...
April 19, 2018

Kalytera Announces Issuance of Patent Covering the Use of CBD for the Treatment of Severe and Refractory Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY. OTCQB:KALTF) announced that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No. 9,889,100 B2...